SegRap2023: A Benchmark of Organs-at-Risk and Gross Tumor Volume Segmentation for Radiotherapy Planning of Nasopharyngeal Carcinoma
Authors:
Xiangde Luo,
Jia Fu,
Yunxin Zhong,
Shuolin Liu,
Bing Han,
Mehdi Astaraki,
Simone Bendazzoli,
Iuliana Toma-Dasu,
Yiwen Ye,
Ziyang Chen,
Yong Xia,
Yanzhou Su,
** Ye,
Junjun He,
Zhaohu Xing,
Hongqiu Wang,
Lei Zhu,
Kaixiang Yang,
Xin Fang,
Zhiwei Wang,
Chan Woong Lee,
Sang Joon Park,
Jaehee Chun,
Constantin Ulrich,
Klaus H. Maier-Hein
, et al. (17 additional authors not shown)
Abstract:
Radiation therapy is a primary and effective NasoPharyngeal Carcinoma (NPC) treatment strategy. The precise delineation of Gross Tumor Volumes (GTVs) and Organs-At-Risk (OARs) is crucial in radiation treatment, directly impacting patient prognosis. Previously, the delineation of GTVs and OARs was performed by experienced radiation oncologists. Recently, deep learning has achieved promising results…
▽ More
Radiation therapy is a primary and effective NasoPharyngeal Carcinoma (NPC) treatment strategy. The precise delineation of Gross Tumor Volumes (GTVs) and Organs-At-Risk (OARs) is crucial in radiation treatment, directly impacting patient prognosis. Previously, the delineation of GTVs and OARs was performed by experienced radiation oncologists. Recently, deep learning has achieved promising results in many medical image segmentation tasks. However, for NPC OARs and GTVs segmentation, few public datasets are available for model development and evaluation. To alleviate this problem, the SegRap2023 challenge was organized in conjunction with MICCAI2023 and presented a large-scale benchmark for OAR and GTV segmentation with 400 Computed Tomography (CT) scans from 200 NPC patients, each with a pair of pre-aligned non-contrast and contrast-enhanced CT scans. The challenge's goal was to segment 45 OARs and 2 GTVs from the paired CT scans. In this paper, we detail the challenge and analyze the solutions of all participants. The average Dice similarity coefficient scores for all submissions ranged from 76.68\% to 86.70\%, and 70.42\% to 73.44\% for OARs and GTVs, respectively. We conclude that the segmentation of large-size OARs is well-addressed, and more efforts are needed for GTVs and small-size or thin-structure OARs. The benchmark will remain publicly available here: https://segrap2023.grand-challenge.org
△ Less
Submitted 15 December, 2023;
originally announced December 2023.
Fully Automatic Segmentation of Gross Target Volume and Organs-at-Risk for Radiotherapy Planning of Nasopharyngeal Carcinoma
Authors:
Mehdi Astaraki,
Simone Bendazzoli,
Iuliana Toma-Dasu
Abstract:
Target segmentation in CT images of Head&Neck (H&N) region is challenging due to low contrast between adjacent soft tissue. The SegRap 2023 challenge has been focused on benchmarking the segmentation algorithms of Nasopharyngeal Carcinoma (NPC) which would be employed as auto-contouring tools for radiation treatment planning purposes. We propose a fully-automatic framework and develop two models f…
▽ More
Target segmentation in CT images of Head&Neck (H&N) region is challenging due to low contrast between adjacent soft tissue. The SegRap 2023 challenge has been focused on benchmarking the segmentation algorithms of Nasopharyngeal Carcinoma (NPC) which would be employed as auto-contouring tools for radiation treatment planning purposes. We propose a fully-automatic framework and develop two models for a) segmentation of 45 Organs at Risk (OARs) and b) two Gross Tumor Volumes (GTVs). To this end, we preprocess the image volumes by harmonizing the intensity distributions and then automatically crop** the volumes around the target regions. The preprocessed volumes were employed to train a standard 3D U-Net model for each task, separately. Our method took second place for each of the tasks in the validation phase of the challenge. The proposed framework is available at https://github.com/Astarakee/segrap2023
△ Less
Submitted 4 October, 2023;
originally announced October 2023.
AutoPaint: A Self-Inpainting Method for Unsupervised Anomaly Detection
Authors:
Mehdi Astaraki,
Francesca De Benetti,
Yousef Yeganeh,
Iuliana Toma-Dasu,
Örjan Smedby,
Chunliang Wang,
Nassir Navab,
Thomas Wendler
Abstract:
Robust and accurate detection and segmentation of heterogenous tumors appearing in different anatomical organs with supervised methods require large-scale labeled datasets covering all possible types of diseases. Due to the unavailability of such rich datasets and the high cost of annotations, unsupervised anomaly detection (UAD) methods have been developed aiming to detect the pathologies as devi…
▽ More
Robust and accurate detection and segmentation of heterogenous tumors appearing in different anatomical organs with supervised methods require large-scale labeled datasets covering all possible types of diseases. Due to the unavailability of such rich datasets and the high cost of annotations, unsupervised anomaly detection (UAD) methods have been developed aiming to detect the pathologies as deviation from the normality by utilizing the unlabeled healthy image data. However, developed UAD models are often trained with an incomplete distribution of healthy anatomies and have difficulties in preserving anatomical constraints. This work intends to, first, propose a robust inpainting model to learn the details of healthy anatomies and reconstruct high-resolution images by preserving anatomical constraints. Second, we propose an autoinpainting pipeline to automatically detect tumors, replace their appearance with the learned healthy anatomies, and based on that segment the tumoral volumes in a purely unsupervised fashion. Three imaging datasets, including PET, CT, and PET-CT scans of lung tumors and head and neck tumors, are studied as benchmarks for evaluation. Experimental results demonstrate the significant superiority of the proposed method over a wide range of state-of-the-art UAD methods. Moreover, the unsupervised method we propose produces comparable results to a robust supervised segmentation method when applied to multimodal images.
△ Less
Submitted 21 May, 2023;
originally announced May 2023.
